Clarkston Shares Guest Column on Federal Workforce Reduction Impacts the Life Sciences Industry
June 9, 2025 | Clarkston Consulting’s Liz McGuire recently shared a guest column with Outsourced Pharma on how the reduction of the federal workforce poses serious challenges for U.S . scientific innovation and how building a resilient and responsive life sciences supply chain takes ongoing investment in research, regulation, and innovation. Read an excerpt below and the full article here.
Bracing For The Impact Of The Federal Workforce Reduction
“Federal workforce reductions pose significant challenges for the life sciences industry, particularly in sectors like biotechnology, medicine, and biology. In this article, I’ll provide a snapshot of what to expect with how the current reduction in force at the FDA impacts your life sciences company and products.”
Also read on: